# Renova Therapeutics, Inc. — Form D

Renova Therapeutics, Inc. of CARLSBAD, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-09. The offering totals $500K, of which $167K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-09-09
- Form: D
- Accession: 0002036392-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $167K
- Remaining: $334K
- Investors: 7
- Date of first sale: 2024-07-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-523564

## Issuer

- Name: Renova Therapeutics, Inc.
- CIK: 0002036392
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 701 PALOMAR AIRPORT ROAD, CARLSBAD, CA, 92011
- Phone: 8584611837

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Roy Cosan | Director | Carlsbad, CA |
| William Davidson | Director | Carlsbad, CA |
| Kirk Hammond | Director | Carlsbad, CA |
| Pierre Lecocq | Director | Carlsbad, CA |
| Vijay Mahant | Director | Carlsbad, CA |
| Michael Torres | Director | Doral, FL |
| Morgan Xu | Director | Carlsbad, CA |
| Shawn Swaney | Executive Officer | Carlsbad, CA |

## More

- [CIK 2036392 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2036392&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002036392-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.
